Sensilia Laboratory is a French, family-owned and independent laboratory based in Gironde, France. Since 2019, we have been researching and manufacturing healthy, innovative wellness products.
MSM is a popular pick for dog joint health, but the science is limited — and no veterinary studies exist yet.
Published in
Natural IngredientsMSM is appearing more and more often in supplements designed for canine joint comfort. Yet behind this recent popularity lies a little-known reality: MSM remains one of the least scientifically documented ingredients in veterinary medicine.
So, what exactly is MSM? Can it really support the mobility of a dog that is starting to show signs of stiffness? And what do scientific studies say?
This article provides a transparent overview backed by evidence.
MSM, or methylsulfonylmethane, is a small molecule naturally present in the environment and in certain animal tissues. Chemically speaking, it is an organosulfur compound, that is, an organic molecule that contains sulfur.
Sulfur is an essential mineral for mammals. It is found in many tissues: cartilage, tendons, ligaments, skin, hair, as well as in certain amino acids useful for cellular function.
Organosulfur compounds are molecules derived from living organisms that contain a sulfur atom in their structure. This sulfur participates in chemical bonds called "disulfide bridges." These bridges play an important role in protein stability, particularly those that make up connective tissues such as collagen or certain elements of the cartilaginous matrix.
Autrement dit, MSM provides a form of sulfur that is easily usable by the body.
Sulfur is involved in the production or stability of several key elements:
This is why MSM is sometimes highlighted in joint supplements: it provides an essential element for several joint structures.
In supplements, MSM most often comes in the form of purified crystalline powder (generally at 99.9%), sometimes in capsules for humans. It is taken orally, mixed into food or diluted in water.
For dogs, there are products containing MSM alone or combined with other joint ingredients. They come as powder, tablets or soft chews. However, no optimal dose has been determined in dogs, due to a lack of clinical studies, and current recommendations are based mainly on extrapolations from human nutrition.
The proposed mechanisms around MSM come mainly from laboratory studies (on cells) or in species other than the dog. They help to better understand its theoretical interest, but do not prove its clinical efficacy.
Much of joint discomfort is linked to local inflammation. In several in vitro studies, MSM appears to reduce the activity of certain inflammatory mediators such as:
In other words, this research suggests that MSM may limit the activation of these inflammatory pathways.
It is however important to note that these observations have never been confirmed in dog joints.
The joint naturally produces free radicals, unstable molecules that, in excess, contribute to cartilage wear. At high concentrations, these free radicals can damage cartilage cells, alter the extracellular matrix, and sustain inflammation.
In several experimental models, MSM has stimulated the activity of antioxidant enzymes such as superoxide dismutase (SOD) and reduced certain markers of cellular oxidation.
These results suggest that it could play a protective role against oxidative stress, even if this has not been demonstrated in dogs.
Cartilage and the tissues surrounding the joint rely on molecules that require sulfur to be properly manufactured, including:
By providing a readily assimilable source of sulfur, MSM could theoretically help maintain these cartilaginous structures.
However, no study has shown that this intake translates into improved mobility or joint comfort in dogs.
Comme il n’existe no study on MSM in dogs, we must look at what has been done in humans and in animal models. Studies are few in number and their results show modest effects.
The first data come from a randomized trial conducted by Kim et al. (2006) in 50 adults with knee osteoarthritis. Participants received 3.375 g/day of MSM or a placebo for twelve weeks. Pain scores (WOMAC) show a significant improvement in pain and function, but of low magnitude, which limits its clinical relevance. In short: the improvement is real from a statistical standpoint, but too small to represent a major clinical benefit
A more robust study, conducted by Debbi et al. (2011) in 100 osteoarthritis patients, reaches similar conclusions. After twelve weeks of supplementation at 6 g/day, pain and function improve modestly, but blood inflammation markers such as cytokines remain unchanged. The study notes that the observed benefits are 'of low magnitude' and of a uncertain clinical relevance.
The observed improvements are modest and their clinical relevance remains uncertain.
More recently, Kawata et al. (2023) evaluated 2 g/day of MSM in 88 adults with mild knee pain. The pain score (JKOM) improved significantly, but again inflammatory biomarkers (IL-1β, IL-6) show no notable variation. L’effet observé reste essentiellement subjectif et modéré.
Trials report generally good tolerability over 8 to 12 weeks, blood and urine tests without abnormalities, and a few adverse effects such as digestive issues (bloating, mild diarrhoea), occasional headaches.
To date, there is no clinical study evaluating MSM in dogs in the context of joint disorders.
No randomised trial, no dose-ranging study, and no pain or mobility measurement has been published in veterinary medicine. The proposed mechanisms and results observed in humans or animal models therefore cannot be reliably extrapolated to dogs.
In the current state of knowledge, the actual efficacy of MSM on mobility or joint comfort in dogs remains unknown.
In the absence of studies conducted in dogs, it is difficult to recommend MSM as a reliable solution for joint comfort. Research in humans shows a real but modest effect, and animal models provide only theoretical leads, sometimes observed at very high doses that would not be transferable to a companion animal.
This does not mean that MSM is dangerous: available data suggest good short-term tolerability, mainly with some digestive issues reported in humans. But due to a lack of veterinary trials, its actual benefit for mobility, pain or quality of life in dogs remains unknown.
In practice, MSM can be considered as a secondary supplement, but it should not replace approaches whose efficacy is demonstrated in dogs: weight management, adapted activity, balanced diet, and better-documented supplements such as Omega-3 EPA+DHA or 'green lipped mussel oil.
Discover our comparison of joint supplements for dogs
In summary, MSM can be integrated into an overall strategy, but its efficacy on joint disorders in dogs has not been demonstrated. Any use should be discussed with a veterinarian, especially if the dog has established pain, persistent lameness or ongoing medical treatment.
MSM is often presented as a complementary treatment, but the evidence remains limited. Human studies show a real but modest effect, and no clinical work has been conducted in dogs. Based on current knowledge, MSM can be considered as a secondary supplement, but should not replace solutions whose efficacy has been demonstrated in veterinary medicine, such as Omega-3 or green lipped mussel oil. Any decision regarding its use should remain individualized and discussed with a veterinarian.
This article was written by the R&D team at Laboratoire Sensilia, experts in animal nutrition.